Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Journal of Immunotoxicology|November 9, 2011
Survey: immune function and immunotoxicity assessment in dogsHervé Lebrec, Raegan O'Lone, Wendy Freebern, et al.Comparative Medicine|July 5, 2015
Severe Acquired Idiopathic Thrombocytopenia in a Female Cynomolgus Macaque (Macaca fascicularis)Cecilia M Parrula, Jagannatha Mysore, Holly Burr, et al.Toxicology and Applied Pharmacology|October 18, 2020
Decreased immune response in monkeys administered a human T-effector cell agonist (OX40) antibodyJoshua T Gamse, Wendy Freebern, Rashade Haynes Ii, et al.Journal of Immunotoxicology|February 15, 2023
Current approaches to evaluate the function of cytotoxic T-cells in non-human primatesCris Kamperschroer, Brendon Frank, Caroline Genell, et al.Regulatory Toxicology and Pharmacology : RTP|November 21, 2020
Industry experiences with immune-mediated findings in biotherapeutic nonclinical toxicology studiesTimothy K MacLachlan, Sven Kronenberg, Nikki Marshall, et al.Journal of Immunotoxicology|March 4, 2020
Cross-company evaluation of the human lymphocyte activation assayMark Collinge, Patricia Schneider, Dingzhou Li, et al.Regulatory Toxicology and Pharmacology : RTP|February 26, 2014
The T-cell-dependent antibody response assay in nonclinical studies of pharmaceuticals and chemicals: study design, data analysis, interpretationHervé Lebrec, Brigitte Molinier, Darrell Boverhof, et al.Drug Discovery Today|November 14, 2022
Current nonclinical approaches for immune assessments of immuno-oncology biotherapeuticsChristine Grimaldi, Alex Ibraghimov, Andrea Kiessling, et al.Regulatory Toxicology and Pharmacology : RTP|January 2, 2023
Re-evaluating the need for chronic toxicity studies with therapeutic monoclonal antibodies, using a weight of evidence approachHsiao-Tzu Chien, Helen Prior, Laura Andrews, et al.Regulatory Toxicology and Pharmacology : RTP|January 17, 2023
The use of recovery animals in nonclinical safety assessment studies with monoclonal antibodies: further 3Rs opportunities remainHelen Prior, Laura Andrews, Annick Cauvin, et al.Pageof 2